Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
McKesson
Mallinckrodt
Farmers Insurance
UBS

Generated: March 25, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CEFTAZIDIME

« Back to Dashboard

Clinical Trials for Ceftazidime

Trial ID Title Status Sponsor Phase Summary
NCT00173901 Adverse Drug Reactions of Different Brands of Ceftazidime Injection Unknown status National Taiwan University Hospital Phase 4 The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.
NCT00210964 Ceftobiprole in Hospital Acquired Pneumonia Completed Basilea Pharmaceutica Phase 3 The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
NCT00229008 Ceftobiprole in Hospital Acquired Pneumonia Completed Basilea Pharmaceutica Phase 3 The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ceftazidime

Condition Name

Condition Name for Ceftazidime
Intervention Trials
Pneumonia 5
Cystic Fibrosis 4
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ceftazidime
Intervention Trials
Infection 14
Communicable Diseases 13
Urinary Tract Infections 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ceftazidime

Trials by Country

Trials by Country for Ceftazidime
Location Trials
United States 80
India 11
Spain 11
Poland 8
Czech Republic 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ceftazidime
Location Trials
California 10
Ohio 8
Michigan 6
Texas 5
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ceftazidime

Clinical Trial Phase

Clinical Trial Phase for Ceftazidime
Clinical Trial Phase Trials
Phase 4 9
Phase 3 13
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ceftazidime
Clinical Trial Phase Trials
Completed 27
Recruiting 7
Unknown status 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ceftazidime

Sponsor Name

Sponsor Name for Ceftazidime
Sponsor Trials
AstraZeneca 17
Forest Laboratories 7
Basilea Pharmaceutica 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ceftazidime
Sponsor Trials
Industry 36
Other 35
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.